Synthesis and Biological Evaluation of Panaxatriol Derivatives Against Myocardial Ischemia/reperfusion Injury in the Rat

Qiong Wu,Ruiying Wang,Yang Shi,Wenchao Li,Meng Li,Peng Chen,Bowen Pan,Qing Wang,Caifeng Li,Jianbing Wang,Guibo Sun,Xiaobo Sun,Hongzheng Fu

DOI: https://doi.org/10.1016/j.ejmech.2019.111729

IF: 7.088

2020-01-01

European Journal of Medicinal Chemistry

Abstract:Panaxatriol (PT) is a natural product derived from ginseng that possesses cardioprotective effects in isolated rat hearts. To develop more potent therapeutic agents against myocardial ischemia/reperfusion (MI/R) injury from natural products, a novel series of heterocycle ring-fused panaxatriol derivatives were designed and synthesized. In vitro results showed that approximately half of them exhibited increased cytoprotective activity compared with PT in a cardiomyocyte model of oxygen-glucose deprivation and reperfusion (OGD/R) injury. Furthermore, the in vitro activity of the representative derivative, compound 18, was also confirmed in a rat model of MI/R injury. In vivo results showed that 18 can markedly reduce myocardial infarction size, decrease circulating cardiac troponin I (cTnI) leakage, and alleviate cardiac tissue damage in the rats. Therefore, these findings provide the basis for further development of novel anti-MI/R injury agents.